z-logo
open-access-imgOpen Access
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Author(s) -
Susheel Kodali,
Mathew Williams,
Craig R. Smith,
Lars G. Svensson,
John G. Webb,
Raj Makkar,
Gregory P. Fontana,
Todd Dewey,
Vinod H. Thourani,
Augusto D. Pichard,
Michael P. Fischbein,
Wilson Y. Szeto,
Scott Lim,
Kevin L. Greason,
Paul S. Teirstein,
S. Chris Malaisrie,
Pamela S. Douglas,
Rebecca T. Hahn,
Brian Whisenant,
Alan Zajarías,
Duolao Wang,
Jodi J. Akin,
William N. Anderson,
Martin B. Leon
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1200384
Subject(s) - medicine , valve replacement , surgery , aortic valve replacement , aortic valve , medline , cardiology , stenosis , political science , law
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that among high-risk patients with aortic stenosis, the 1-year survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical replacement. However, longer-term follow-up is necessary to determine whether TAVR has prolonged benefits.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom